Finance Watch: Venture Capital On Track For Another Record Year
$20.3bn Raised In H1 2021 Versus $27.2bn For All Of 2020
Private Company Edition: With $8.9bn raised in the second quarter, venture capital investment in biopharma companies reached its second highest quarterly total to date – behind only Q1 of this year. Also, Nimbus Therapeutics raised $105m and European drug developers get in on the VC action.
